{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:03:43Z","timestamp":1772838223951,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejso.2025.110395","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:11:20Z","timestamp":1755501080000},"page":"110395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A standardized surgical approach to multifocal locoregionally recurrent left-sided adrenocortical carcinoma"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-1032","authenticated-orcid":false,"given":"Shruthi R.","family":"Perati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8354-0881","authenticated-orcid":false,"given":"Alyssa V.","family":"Eade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Dinerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Barrows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4618-5158","authenticated-orcid":false,"given":"Rachael","family":"Lowney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-4816","authenticated-orcid":false,"given":"Lindsay R.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7880-2183","authenticated-orcid":false,"given":"Tracey","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4773-2632","authenticated-orcid":false,"given":"Carolina","family":"Larrain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Sarvestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen","family":"Hannah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamika","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5013-3851","authenticated-orcid":false,"given":"Andrew M.","family":"Blakely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-6936","authenticated-orcid":false,"given":"Jeremy L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naris N.","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaydira","family":"del Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2025.110395_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.14740\/jocmr3503w","article-title":"The characteristics and trends in adrenocortical carcinoma: a United States population based study","volume":"10","author":"Sharma","year":"2018","journal-title":"J Clin Med Res"},{"issue":"2","key":"10.1016\/j.ejso.2025.110395_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"23","key":"10.1016\/j.ejso.2025.110395_bib3","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2025.110395_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1245\/s10434-015-4810-y","article-title":"Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence","volume":"23","author":"Amini","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110395_bib5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/oncolo\/oyae029","article-title":"Adrenocortical carcinomas: molecular pathogenesis, treatment options, and emerging immunotherapy and targeted therapy approaches","volume":"29","author":"Chukkalore","year":"2024","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejso.2025.110395_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/000313481908500111","article-title":"Operative management of recurrent and metastatic adrenocortical carcinoma: a systematic review","volume":"85","author":"Lo","year":"2019","journal-title":"Am Surg"},{"issue":"11","key":"10.1016\/j.ejso.2025.110395_bib7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110395_bib8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jamcollsurg.2016.08.568","article-title":"Clinical score predicting long-term survival after repeat resection for recurrent adrenocortical carcinoma","volume":"223","author":"Tran","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"7","key":"10.1016\/j.ejso.2025.110395_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jso.23015","article-title":"Operative management for recurrent and metastatic adrenocortical carcinoma","volume":"105","author":"Datrice","year":"2012","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110395_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.amjsurg.2022.08.020","article-title":"Higher SUV(max) on FDG-PET is associated with shorter survival in adrenocortical carcinoma","volume":"225","author":"Wrenn","year":"2023","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.110395_bib11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s12020-024-03695-6","article-title":"Prognostic role of quantitative [18F]FDG PET\/CT parameters in adrenocortical carcinoma","volume":"84","author":"Schlotelburg","year":"2024","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ejso.2025.110395_bib12","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.3390\/curroncol28060370","article-title":"Tumor doubling time using CT volumetric segmentation in metastatic adrenocortical carcinoma","volume":"28","author":"Fuller","year":"2021","journal-title":"Curr Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2025.110395_bib14","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","article-title":"A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC quality of life group","volume":"36","author":"Bjordal","year":"2000","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.110395_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejso.2025.110395_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the european organisation for the research and treatment of cancer quality of life questionnaire core 30","volume":"29","author":"Cocks","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110395_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s43163-024-00642-0","article-title":"Cut-off points to classify numeric values of quality of life into normal, mild, moderate, and severe categories: an update for EORTC-QLQ-H&N35","volume":"40","author":"Saini","year":"2024","journal-title":"The Egyptian Journal of Otolaryngology"},{"issue":"11","key":"10.1016\/j.ejso.2025.110395_bib18","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1245\/s10434-022-11375-w","article-title":"Technical standards for cancer surgery: commission on cancer standards 5.3-5.8","volume":"29","author":"Katz","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.110395_bib19","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1245\/s10434-022-11330-9","article-title":"Technical standards for cancer surgery: improving patient care through synoptic operative reporting","volume":"29","author":"Hieken","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110395_bib20","series-title":"Protocol for cancer surgery documentation: adrenal cancer","first-page":"21","author":"Barbara","year":"2024"},{"issue":"10","key":"10.1016\/j.ejso.2025.110395_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American association of endocrine surgeons guidelines for adrenalectomy: executive summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2025.110395_bib22","article-title":"Reoperation for recurrent adrenocortical carcinoma: a systematic review and pooled analysis of population-based studies","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Surg"},{"issue":"5","key":"10.1016\/j.ejso.2025.110395_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jjco\/hyac207","article-title":"The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma","volume":"53","author":"Kijima","year":"2023","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110395_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad002","article-title":"The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients","volume":"188","author":"Calabrese","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2025.110395_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/bs.acr.2021.03.008","article-title":"Cisplatin chemotherapy and renal function","volume":"152","author":"Zhang","year":"2021","journal-title":"Adv Cancer Res"},{"issue":"4","key":"10.1016\/j.ejso.2025.110395_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00280-020-04147-4","article-title":"Population pharmacokinetics and renal toxicity of cisplatin in cancer patients with renal dysfunction","volume":"86","author":"Morita-Ogawa","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"issue":"23","key":"10.1016\/j.ejso.2025.110395_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235901","article-title":"Advanced adrenocortical carcinoma: from symptoms control to palliative care","volume":"14","author":"Ruggiero","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:18:52Z","timestamp":1772806732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325008236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0748798325008236"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110395","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A standardized surgical approach to multifocal locoregionally recurrent left-sided adrenocortical carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110395"}}